GramEye
PrivateLast Round
Series B
Nov 21, 2025
Total Funding Raised
$6.09M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GramEye operates in Healthcare & Life Sciences and is based in Ibaraki. Its latest recorded funding round was a Series B round in November 2025.
GramEye is a medical technology company that develops an AI and robotics solution to automate Gram staining, aiming to facilitate the appropriate use of antimicrobials.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotech Equipment, Computer Vision
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GramEye Comparables
Compare GramEye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neomend | 71% | |
| bioMérieux | 70% | |
| Bruker | 69% |
For institutional investors. Book with your work email.
GramEye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 21, 2025 | ||||
| Series A | Oct 13, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GramEye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DEEPCORE Inc. | Series A |
| Ikeda Senshu Capital | Series A |
| Samurai Incubate Inc. | Series A, Series B |
| NES Inc. | Series A, Series B |
| Beyond Next Ventures | Series B |
| STATION Ai Corporation | Series A |
| SMBC Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 46% MoM, reaching 6K.
- Apr 18, 2026
Monthly visitors increased 55% MoM.
For institutional investors. Book with your work email.
GramEye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GramEye's valuation, stock price, and market status.
Is GramEye a public or private company?
GramEye is a private company.
What is the current stock price of GramEye?
GramEye is a private company, so its shares have no public market price. Caplight tracks GramEye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GramEye worth (valuation)?
Valuation information for GramEye is not publicly available.
Can I buy GramEye stock?
GramEye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GramEye's last funding round?
GramEye's most recent funding round was Series B on November 21, 2025.
Who are the main investors in GramEye?
Key investors in GramEye include Beyond Next Ventures.
Will GramEye IPO soon?
No public IPO plans have been announced for GramEye.
How can I track GramEye secondary market activity?
Caplight tracks bids, offers, and trades in GramEye's shares on secondary markets.